Find the latest pharmaceutical market place for formulations enquiry about Rivaroxaban on PharmaCompass.com.

india-flag Flag

Various RLDs needed in India [ENA19296]

A company with 3 divisions which focuses on manufacturing and development of various finished formulations is looking for suppliers of Various RLDs for development purposes.
1. Rivaroxaban (2.5 mg/ 10 mg/ 15 mg) Tablets
2. Rosuvastatin Calcium (5 mg/ 10 mg/ 20 mg/ 40 mg) Tablets
3. Nortriptyline (10 mg/ 25 mg/ 50 mg/ 75 mg) Capsules
4. Febuxostat (40 mg/ 80 mg) Tablets
5. Betahistine (8 mg/ 16 mg) Tablets
6. Dapagliflozin (5 mg/10 mg) Tablets
7. Empagliflozin (10 mg/ 25 mg) Tablets
8. Vonoprazan Fumarate (10 mg/ 20 mg) Tablets

Reply

04 Apr 2024

Tender// Various Finished Dosage Formulations needed in Croatia [ENA15254]

Klinicka bolnica Dubrava is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 7-Nov-2022.
1. Rivaroxaban (15 mg) Film-Coated Tablets. The required quantity is 2,800 units.
2. Dabigatran Etexilate (110 mg) Capsules. The required quantity is 1,500 units.

Reply

08 Oct 2022

MyanmarBurma Flag

Various Finished Dosage Formulations needed in Myanmar [ENA14525]

A large pharmaceutical company based in India that focuses in various segments such as gynaecology, cardiovascular, diabetology, asthma, paediatric, CNS, GI and NSAIDs is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with ACTD dossier & WHO-GMP/ PICs.
1. Apixaban (5 mg) Tablets
2. Rivaroxaban (10 mg) Tablets
3. Posaconazole (100 mg) DR Tablets

Reply

30 Jul 2022

Various Finished Dosage Formulations needed in Vietnam [ENA13102]

A large pharmaceutical company based in India that deals in various segments such as gynaecology, cardiovascular, diabetology, asthma, paediatric, CNS, GI and NSAIDs is looking for suppliers of Various Finished Dosage Formulations for commercial purpose.
1. Rivaroxaban (10 mg, 15 mg & 20 mg) Tablets
2. Erythropoietin (2000 IU) Injections
3. Doripenem (250 mg & 500 mg) Injections

Reply

25 Mar 2022

Various Finished Dosage Formulations needed in Brazil [ENA12424]

A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with CTD Dossier, ANVISA, DMF & PIC/s GMP.
1. Semaglutide (4 mg in 3 ml & 2 mg in 1.5 ml) Prefilled Syringes. The required quantity is 1 million units & 500,000 units respectively.
2. Liraglutide (6 mg in 3 ml & 6 mg in 2 ml) Prefilled Syringes. The required quantity is 1 million units for each.
3. Paclitaxel (100 mg in 16.7 ml & 300 mg in 50 ml) Prefilled Syringes. The required quantity is 5 million units for each.
4. Rivaroxaban (20 mg, 15 mg & 10 mg) Coated Tablets. The required quantity is 100 million units, 80 million units & 70 million units respectively.
5. Nivolumab (100 mg in 10 ml & 40 mg in 4 ml) IV Solution. The required quantity is 200 million units & 100 million units respectively.

Reply

17 Jan 2022

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA11970]

Fouth Multiprofile Hospital for Active Treatment - Sofia EAD is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 10-Dec-2021.
1. Nadroparin Calcium (0.6 ml & 0.4 ml) Ampoules. The required quantity is 7,200 units for each.
2. Rivaroxaban (15 mg) Tablets. The required quantity is 1,008 units.
3. Spironolactone (25 mg) Tablets. The required quantity is 1,300 units.
4. Dexamethasone (4 mg in 1 ml) Ampoules. The required quantity is 7,000 units.

Reply

30 Nov 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA10922]

Specialist Hospital of Ludwik Rydygiera in Krakow limited liability company is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 20-Aug-2021.
1. Amlodipine (10 mg) Pills. The required quantity is 9,000 units.
2. Carbamazepine (200 mg) Divisible Tablets. The required quantity is 2,500 units.
3. Carvedilol (6.25 mg) Pills. The required quantity is 9,000 units.
4. Methylprednisolone (4 mg & 10 mg) Pills. The required quantity is 4,500 units & 7,500 units respectively.
5. Pantoprazole (40 mg) Gastro-Resistant Tablets. The required quantity is 2,800 units.
6. Spironolactone (25 mg) Pills. The required quantity is 20,000 units.
7. Bupivacaine (50 mg/ 10 ml) Solution for Injection. The required quantity is 4,000 units.
8. Rivaroxaban (15 mg) Coated Tablets. The required quantity is 7,000 units.
9. Gliclazide (60 mg) Oral Prolonged Release Tablets. The required quantity is 7,200 units.
10. Indapamide (1.5 mg) Oral Prolonged Release Tablets. The required quantity is 16,200 units.
11. Perindoprilum (5 mg) Coated Tablets. The required quantity is 9,000 units.
12. Aciclovir (250 mg) Vials. The required quantity is 1,500 units.
13. Hydrocortisone (100 mg) Ampoules/ Vials. The required quantity is 6,000 units.

Reply

21 Jul 2021

Various Finished Dosage Formulations required with CTD Dossiers needed in Ukraine [ENA07186]

A pharmaceutical manufacturing company that deals in portfolios like antibiotics, antitussive, painkillers, anti-anemic & many more is looking for suppliers of Various Finished Dosage Formulations. The end market are CIS countries (Kazakhistan, Azerbaijan, Uzbekistan & Ukraine). The suppliers must support this enquiry with CPP.
1. Ademetionine 400 mg Tablet (10,000 units in 20 pack size)
2. Candesartan + Amlodipine + HCTZ (16 mg + 5 mg + 12.5 mg and 16 mg + 10 mg + 12.5 mg) Tablet (20,000 units in 28 pack size for each)
3. Finasteride 5 mg + Tadalafil 5 mg Tablet (10,000 units in 28 pack size)
4. Olmesartan + Amlodipine + HCTZ (20 mg + 5 mg + 12.5 mg and 40 mg + 5 mg + 12.5 mg) Tablet (20,000 units in 28 pack size for each)
5. Solifenacin 6 mg + Tamsolusin 0.4 mg Tablet (20,000 units in 30 pack size)
6. Rivaroxaban 2.5 mg, 10 mg, 15, mg, 20 mg Tablet

Reply

29 Apr 2020

Rivaroxaban Tablets needed in Colombia [ENA05955]

A Taiwanese pharmaceutical company that looks for quality pharmaceutical OEMs and sells them to foreign customers is looking for suppliers of Rivaroxaban 15 mg tablets.

Reply

05 Dec 2019

Rivaroxaban Tablets (Supply+CTD dossier) needed in Georgia [ENA04649]

A large pharmaceutical enterprise of European standards is looking for suppliers of Rivaroxaban Tablets (Supply+CTD dossier). The supplier must support this enquiry with GMP. The required quantity for Rivaroxaban Tablets is about:
1. Rivaroxaban 10 mg - 42,000 tablets
2. Rivaroxaban 20 mg - 140,000 tablets

Reply

18 Jul 2019

CTD dossier of Rivaroxaban 10 mg, 15 mg and 20 mg film-coated tablets needed in Algeria [ENA03603]

An Algerian pharmaceutical company with 20 years of experience in the field of packaging and manufacturing of the drug is looking for CTD dossier of Rivaroxaban 10 mg, 15 mg and 20 mg film-coated tablets.

Reply

06 Mar 2019

Enquiry// Rivaroxaban dossiers needed in China [ENA00457]

A medical marketing company in China is searching for reliable Finished dosage formulations manufacturers in India to work together for Rivaroxaban and other products.

Reply

18 Aug 2017

EU CTD Dossiers Available // Looking for Marketing Partners in the EU for various products [ENA00142]

Inventia Healthcare, one of the leading drug delivery companies in India is searching for partners in Europe for the following products which are at various stages of development -

Approved MA:
1. Duloxetine DR Capsules 30 mg/ 60 mg

Products Under development:
1. Gliclazide MR Tablets 30 mg/ 60 mg - EU fillable dossier will be ready by Oct 2017
2. Ezetimibe 10 mg Tablets - EU fillable dossier will be ready by Dec 2017

Products developed against international innovators and easily extendable to EU
1. Metformin SR Tablets 500 mg
2. Metformin SR Tablets 750 mg
3. Metformin SR Tablets 1000 mg
4. Darifenacin ER tablets 7.5 mg/ 15 mg

New Products Under development for EU
1. Rivaroxaban Tablets 10mg, 15 mg, 20 mg: will be ready by Q3 2019
2. Sitagliptin + Metformin: Target to be ready by Q2 2022
3. Mesalamine 1200 Gm Tablets - Target to be ready by Q3 2019

Interested partners should contact Priyanka Dhanjal at priyanka.dhanjal@inventiahealthcare.com or call +919987152274

Reply

02 Jan 2017

Enquiry//Rosuvastatin and Rivaroxaban dossiers needed for Indonesia [EN00421][EN00422]

Babaria IP, a leading provider of intellectual property services in India, is searching for dossiers with completed BE studies for Rivaroxaban and Rosuvastatin on behalf of a leading pharmaceutical company in Indonesia.

Reply

26 Jun 2016